Targeting of U2AF65 to sites of active splicing in the nucleus.
about
Coiled bodies and gems: Janus or gemini?Differential effects of Notch ligands Delta-1 and Jagged-1 in human lymphoid differentiationThe MUC1 extracellular domain subunit is found in nuclear speckles and associates with spliceosomesAn interaction between U2AF 65 and CF I(m) links the splicing and 3' end processing machineriesRBM20, a gene for hereditary cardiomyopathy, regulates titin splicingThe splicing regulator TIA-1 interacts with U1-C to promote U1 snRNP recruitment to 5' splice sites.Human splicing factor SF3a, but not SF1, is essential for pre-mRNA splicing in vivoU2 small nuclear ribonucleoprotein particle (snRNP) auxiliary factor of 65 kDa, U2AF65, can promote U1 snRNP recruitment to 5' splice sitesDeciphering the cellular pathway for transport of poly(A)-binding protein IIThe role of U2AF35 and U2AF65 in enhancer-dependent splicingThe conserved RNA recognition motif 3 of U2 snRNA auxiliary factor (U2AF 65) is essential in vivo but dispensable for activity in vitroPSKH1, a novel splice factor compartment-associated serine kinaseThe spatial targeting and nuclear matrix binding domains of SRm160WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomesDifferential 3' splice site recognition of SMN1 and SMN2 transcripts by U2AF and U2 snRNPSplicing factors SF1 and U2AF associate in extraspliceosomal complexesSubnuclear localization and dynamics of the Pre-mRNA 3' end processing factor mammalian cleavage factor I 68-kDa subunitPhosphorylation regulates the subcellular location and activity of the snail transcriptional repressorU2 snRNP binds intronless histone pre-mRNAs to facilitate U7-snRNP-dependent 3' end formationAn extended U2AF(65)-RNA-binding domain recognizes the 3' splice site signalNucleocytoplasmic shuttling of heterodimeric splicing factor U2AFThe cellular localization of the murine serine/arginine-rich protein kinase CLK2 is regulated by serine 141 autophosphorylationThe nuclear cap-binding complex interacts with the U4/U6·U5 tri-snRNP and promotes spliceosome assembly in mammalian cellsA novel type of splicing enhancer regulating adenovirus pre-mRNA splicing.Masked mRNA is stored with aggregated nuclear speckles and its asymmetric redistribution requires a homolog of Mago nashiPresence of WT1, the Wilm's tumor suppressor gene product, in nuclear poly(A)(+) ribonucleoprotein.Kinetic role for mammalian SF1/BBP in spliceosome assembly and function after polypyrimidine tract recognition by U2AF.Nucleolar localization of RNA binding proteins induced by actinomycin D and heat shock in Trypanosoma cruzi.Regulation of heterogenous nuclear ribonucleoprotein A1 transport by phosphorylation in cells stressed by osmotic shockRegulation of SR protein localization during developmentRNA structure replaces the need for U2AF2 in splicing.Intron retention in the alternatively spliced region of RON results from weak 3' splice site recognition.Identification of a sequence element directing a protein to nuclear specklesPre-mRNA splicing of IgM exons M1 and M2 is directed by a juxtaposed splicing enhancer and inhibitor.Molecular genetic analysis of the heterodimeric splicing factor U2AF: the RS domain on either the large or small Drosophila subunit is dispensable in vivoU2AF1 mutations alter sequence specificity of pre-mRNA binding and splicingGenome-wide identification of functionally distinct subsets of cellular mRNAs associated with two nucleocytoplasmic-shuttling mammalian splicing factors.The human papillomavirus type 16 negative regulatory RNA element interacts with three proteins that act at different posttranscriptional levels.Major phosphorylation of SF1 on adjacent Ser-Pro motifs enhances interaction with U2AF65.Serine phosphorylation of SR proteins is required for their recruitment to sites of transcription in vivo
P2860
Q22066143-E9B60D53-F4CA-4CB1-A16F-8B1F2804F113Q24291744-710E5D8A-CBB7-4FC5-9A6F-7D1E07E37C61Q24297035-BF9F399A-3C5A-4A9F-AF8F-51B8FFCA61DAQ24306150-D9F73CDA-EA84-4E70-B571-F67829FB9B68Q24310828-183BBD17-CE3A-4993-8E0D-768C0FD4C4B1Q24337164-B66D01EC-C7CA-4D55-B787-9C1E51D4089BQ24337926-0E936D11-5DF2-49E9-873F-5498A561F496Q24529945-F3790DEF-5287-4006-AB03-E83BA228B812Q24539711-3CE9E5B4-A6DA-4BA6-A140-6A8A37D20257Q24540026-31B935B7-99BA-4EBE-8DA2-15AA6C3F2F9BQ24540260-EF6D3C1E-122B-447A-847B-06C1DADC094FQ24540428-34EAE234-9C80-4845-BFCC-5B3973FFA796Q24554496-B84C8772-70CF-4343-8303-5CC0E11FEE97Q24596062-284E612F-1A6E-4E91-A9DA-E22933E28CA7Q24651863-16D2E672-EFB1-4CAA-A88B-7F235A077536Q24655500-28AFDBBF-1E27-452A-9489-97BC5A9FF901Q24673285-5B71B569-840B-43DB-9531-D54FF162ABC9Q24679653-7309CDDC-8667-4559-A476-591D98699792Q24685896-09886BFA-02F0-4320-8C33-4EE23D061C34Q27324522-3B3BE83D-CB3C-436C-BC00-EED7E4633B37Q28140485-210BC3AD-04FC-48B8-A72A-31147BDC09AAQ28291347-A7F3AFEE-B07E-422C-A686-4A1D285093D3Q28910445-032E43CC-DBE5-432D-91BD-5F692836C638Q30845738-8C651BF0-D5D3-4EB8-8E27-8AEEB9E69FA1Q31034379-86A9C4D9-960F-4CAD-B4C6-03FD93FC4500Q33883341-70CEDAAE-2455-4949-9663-2A8024C62B10Q33914927-0526A65F-2834-4A7C-9C9E-E1A6D586A2A1Q33918234-3EAF0716-8530-4B9D-A5F0-7F54828EC0CCQ33928652-3C27A470-C0C1-451B-A523-D87B733C0CBAQ33943038-4E4A9721-4AEE-49B0-865B-D0F23EBDD748Q34501702-C88D1638-6842-41E6-B9E4-7E34AF5F1705Q35025393-79033BB6-9752-4A0C-BB1E-4779C22C5236Q35042636-3F444ED0-E8AD-43A7-A8A7-658BFEB39EB4Q35189351-A8FCA12E-FE35-421E-A951-3783AAFDD464Q35195767-E0CDC9E6-BA3F-4510-B55F-EF1942C187FDQ35348356-696F8A45-17A8-4D33-A53C-0D10A7BD7A63Q35630286-B9A2668A-EB3A-4E8D-B44D-224BF068F57BQ35690884-98867B07-9AFC-44FB-BAB4-731B92C73271Q35943674-A4EEE504-AD85-452D-8BC4-8D04DE905C72Q36255596-3C2C41EC-B1C3-4E3B-A959-18CC2C589700
P2860
Targeting of U2AF65 to sites of active splicing in the nucleus.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Targeting of U2AF65 to sites of active splicing in the nucleus.
@ast
Targeting of U2AF65 to sites of active splicing in the nucleus.
@en
type
label
Targeting of U2AF65 to sites of active splicing in the nucleus.
@ast
Targeting of U2AF65 to sites of active splicing in the nucleus.
@en
prefLabel
Targeting of U2AF65 to sites of active splicing in the nucleus.
@ast
Targeting of U2AF65 to sites of active splicing in the nucleus.
@en
P2093
P2860
P50
P356
P1476
Targeting of U2AF65 to sites of active splicing in the nucleus.
@en
P2093
P2860
P304
P356
10.1083/JCB.137.5.975
P407
P577
1997-06-01T00:00:00Z